Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Subclassification of Erdheim-Chester Disease: Distinct Clinical and Molecular Findings between Classical and Non-Classical Forms

Blood (2024) 144 (Supplement 1): 3181.

https://doi.org/10.1182/blood-2024-193841

Published: 2024

Journal Articles

Cardiovascular Morbidity in Erdheim-Chester Disease (ECD) Patients with and without Cardiac Involvement

Reema K Tawfiq, Jason R Young, Madeline Mahowald, Saurabh Zanwar, Gordon J Ruan, Karen L Rech, Matthew J Koster, Lucinda Gruber, Aishwarya Ravindran, Mithun V Shah, N. Nora Bennani, Robert Vassallo, Jay Ryu, Caroline Davidge-Pitts, Surendra Dasari, Thomas E. Witzig, Ronald S. Go, Gaurav Goyal, Jithma Prasad Abeykoon

Blood (2023) 142 (Supplement 1): 4569.

https://doi.org/10.1182/blood-2023-180322

Published: 2023

Journal Articles

BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

Blood (2023) 142 (18): 1570–1575.

https://doi.org/10.1182/blood.2023021212

Published: 2023

Includes: Supplemental data

Journal Articles

Molecular Findings on Plasma Cell-Free DNA Analysis Among Adults with Histiocytic Neoplasms

Blood (2023) 142 (Supplement 1): 6332.

https://doi.org/10.1182/blood-2023-187500

Published: 2023

Journal Articles

Efficacy of MEK Inhibitors in Erdheim Chester Disease

Aldo A. Acosta Medina, Saurabh Zanwar, Gordon Ruan, Jithma P. Abeykoon, Karen Rech, Aishwarya Ravindran, N. Nora Bennani, Caroline J Davidge-Pitts, Matthew Koster, Jay Ryu, Mithun V. Shah, W. Oliver Tobin, Robert Vassallo, Jason R. Young, Gaurav Goyal, Ronald Go

Blood (2022) 140 (Supplement 1): 9733–9734.

https://doi.org/10.1182/blood-2022-163674

Published: 2022

Journal Articles

High Prevalence of Epigenetic Mutations in Histiocytic and Dendritic Cell Disorders: Results from Molecular Analysis of a Large Cohort from Histiocytosis Working Group

Blood (2022) 140 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2022-162855

Published: 2022

Journal Articles

Mutational Profiling of Rosai-Dorfman Disease and Association with Phenotype: A Multi-Institutional Study

Gordon Ruan, Jithma P. Abeykoon, Aldo A. Acosta Medina, Saurabh Zanwar, Aishwarya Ravindran, Karen Rech, Jason R. Young, Jay Ryu, Matthew Koster, W. Oliver Tobin, Mithun V. Shah, N. Nora Bennani, Robert Vassallo, Baylie Brooks, Ginny-Tyler Meadows, Abby McCrory, Diana Morlote, Gaurav Goyal, Ronald Go

Blood (2022) 140 (Supplement 1): 3995–3996.

https://doi.org/10.1182/blood-2022-159714

Published: 2022

Journal Articles

International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults

Gaurav Goyal, Abdellatif Tazi, Ronald S. Go, Karen L. Rech, Jennifer L. Picarsic, Robert Vassallo, Jason R. Young, Christian W. Cox, Jan Van Laar, Michelle L. Hermiston, Xin-Xin Cao, Polyzois Makras, Gregory Kaltsas, Julien Haroche, Matthew Collin, Kenneth L. McClain, Eli L. Diamond, Michael Girschikofsky

Blood (2022) 139 (17): 2601–2621.

https://doi.org/10.1182/blood.2021014343

Published: 2022

Includes: Supplemental data

Journal Articles

Classical and Non-Classical Phenotypes of Erdheim-Chester Disease: Correlating Clinical, Radiographic, and Genotypic Findings

Antonious Z. Hazim, Gordon Ruan, Aldo A. Acosta-Medina, Jithma P. Abeykoon, Aishwarya Ravindran, Robert Vassallo, Jay Ryu, W. Oliver Tobin, Matthew Koster, N Nora Bennani, Karen Rech, Mithun V. Shah, Jason R. Young, Gaurav Goyal, Ronald Go

Blood (2021) 138 (Supplement 1): 2566.

https://doi.org/10.1182/blood-2021-144786

Published: 2021

Journal Articles

Efficacy of Cobimetinib in Rosai-Dorfman Disease

Jithma P. Abeykoon, Karen Rech, Aishwarya Ravindran, Aldo A. Acosta-Medina, Saurabh Zanwar, Jason R. Young, W. Oliver Tobin, Mithun V. Shah, Nora Bennani, Robert Vassallo, Jay Ryu, Matthew Koster, Caroline J Davidge-Pitts, Gaurav Goyal, Ronald Go

Blood (2021) 138 (Supplement 1): 1506.

https://doi.org/10.1182/blood-2021-149912

Published: 2021

Journal Articles

The Role of Staging Evaluation at Initial Diagnosis of Adult Patients with Clinically Isolated Pulmonary Langerhans Cell Histiocytosis

Antonious Hazim, Gordon Ruan, MD, Aishwarya Ravindran, MBBS, Jithma P. Abeykoon, MD, Caleb J Scheckel, DO, Robert Vassallo, MD, Jay Ryu, MD, W. Oliver Tobin, MB BCh, Matthew Koster, MD, Nabila Bennani, MD, Karen Rech, MD, Jason R Young, MD, Mithun Vinod Shah, MD PhD, Gaurav Goyal, MD, Ronald S. Go, MD

Blood (2020) 136 (Supplement 1): 45.

https://doi.org/10.1182/blood-2020-136861

Published: 2020

Journal Articles

Clinical Features and Outcomes of Unifocal Adult Langerhans Cell Histiocytosis

Marie Hu, MD, Gaurav Goyal, MBBS, Jason Young, MD, Karen Rech, MD, N. Nora Bennani, MD, Mithun Vinod Shah, MD PhD, Robert Vassallo, MD, Jay H Ryu, MD, Ronald S. Go, MD

Blood (2019) 134 (Supplement_1): 1667.

https://doi.org/10.1182/blood-2019-132104

Published: 2019

Journal Articles

Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell Histiocytosis

Gaurav Goyal, MBBS, Marie Hu, MD, Jithma P. Abeykoon, MD, Nora N Bennani, MD, Jay H Ryu, MD, Mithun Vinod Shah, MD PhD, Robert Vassallo, MD, Ronald S. Go, MD

Blood (2019) 134 (Supplement_1): 4189.

https://doi.org/10.1182/blood-2019-122334

Published: 2019

Journal Articles

Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms

Gaurav Goyal, Denise Lau, Alison M. Nagle, Robert Vassallo, Karen L. Rech, Jay H. Ryu, Caroline J. Davidge-Pitts, W. Oliver Tobin, Matthew J. Koster, N. Nora Bennani, Mithun V. Shah, Minetta C. Liu, Ronald S. Go

Blood (2019) 133 (14): 1607–1610.

https://doi.org/10.1182/blood-2018-12-893917

Published: 2019

Includes: Supplemental data

Journal Articles

Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing

Gaurav Goyal, MBBS, Robert Vassallo, MD, Karen L Rech, MD, Jay H Ryu, MD, Caroline J Davidge-Pitts, MBBCh, W Oliver Tobin, MBBCh, PhD, Matthew J Koster, MD, Nabila Nora Bennani, MD, Mithun Vinod Shah, MD PhD, Minetta C Liu, MD, Ronald S. Go, MD

Blood (2018) 132 (Supplement 1): 1112.

https://doi.org/10.1182/blood-2018-99-113196

Published: 2018

Journal Articles

Clinical Features and Treatment Approaches in Patients with Rosai-Dorfman Disease: The Mayo Clinic Experience

Gaurav Goyal, MBBS, Aishwarya Ravindran, MBBS, Mrinal M. Patnaik, MDMBBS, Grzegorz S Nowakowski, MD, Gita Thanarajasingam, MD, Thomas M Habermann, MD, Taimur Sher, MD, Karen L Rech, MD, David J Inwards, MD, Patrick B Johnston, MD PhD, Robert Vassallo, MD, Sameer A. Parikh, MD, Ronald S. Go, MD

Blood (2017) 130 (Supplement 1): 3573.

https://doi.org/10.1182/blood.V130.Suppl_1.3573.3573

Published: 2017

Journal Articles

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

Blood (2016) 127 (22): 2672–2681.

https://doi.org/10.1182/blood-2016-01-690636

Published: 2016

Includes: Supplemental data

Journal Articles

Evaluation Of Afuresertib, An Oral Pan-AKT Inhibitor, In Patients With Langerhans Cell Histiocytosis

Robert J. Arceci, M.D., Ph.D., Carl E. Allen, MD, PhD, Ira Dunkel, M.D., Eric D. Jacobsen, MD, James Whitlock, Robert Vassallo, M.D., Ivan M. Borrello, MD, Allen Oliff, MD, Shannon R. Morris, MD, PhD, Beth Ann M Reedy, Alison Portnoy, Deborah A. Smith, PharmD, Bob Noble, Amy A. Murnane, Stephen A. Szabo, Carlos Rodriguez-Galindo, Mark L. Heaney, MD, PhD, Kenneth L. McClain, MD, PhD, Sarah Vaseilbuh, MD

Blood (2013) 122 (21): 2907.

https://doi.org/10.1182/blood.V122.21.2907.2907

Published: 2013

NARROW

Subclassification of Erdheim-Chester Disease: Distinct Clinical and Molecular Findings between Classical and Non-Classical Forms

Cardiovascular Morbidity in Erdheim-Chester Disease (ECD) Patients with and without Cardiac Involvement

BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

Molecular Findings on Plasma Cell-Free DNA Analysis Among Adults with Histiocytic Neoplasms

Efficacy of MEK Inhibitors in Erdheim Chester Disease

High Prevalence of Epigenetic Mutations in Histiocytic and Dendritic Cell Disorders: Results from Molecular Analysis of a Large Cohort from Histiocytosis Working Group

Mutational Profiling of Rosai-Dorfman Disease and Association with Phenotype: A Multi-Institutional Study

International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults

Classical and Non-Classical Phenotypes of Erdheim-Chester Disease: Correlating Clinical, Radiographic, and Genotypic Findings

Efficacy of Cobimetinib in Rosai-Dorfman Disease

The Role of Staging Evaluation at Initial Diagnosis of Adult Patients with Clinically Isolated Pulmonary Langerhans Cell Histiocytosis

Clinical Features and Outcomes of Unifocal Adult Langerhans Cell Histiocytosis

Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell Histiocytosis

Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms

Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing

Clinical Features and Treatment Approaches in Patients with Rosai-Dorfman Disease: The Mayo Clinic Experience

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

Evaluation Of Afuresertib, An Oral Pan-AKT Inhibitor, In Patients With Langerhans Cell Histiocytosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only